Skip to content
Disclosery

PharVision Advisers, LLC: CXM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of PharVision Advisers, LLC on CXM, newest first. How the timeline and the estimate are built.

PharVision Advisers, LLC held 0 CXM shares at 2025-12-31 per its 13F-HR filed 2026-02-17.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -34,307 shares

    13F-HR 0001420506-26-000567 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 34,307 shares
    Change vs previous 13F -13,984 shares

    0.15% of the 13F portfolio, value $264,850.

    13F-HR 0001420506-25-003453 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 48,291 shares
    Change vs previous 13F +25,536 shares

    0.59% of the 13F portfolio, value $408,542.

    13F-HR 0001420506-25-001926 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-03-31
    13F 22,755 shares
    Change vs previous 13F not available

    0.26% of the 13F portfolio, value $190,004.

    13F-HR 0001420506-25-001232 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).